News Detail
![](pdf/NPPA lens220724081244.jpg)
New Delhi, 22 July 2024: The number of cases booked and amount demanded by the National Pharmaceutical Pricing Authority (NPPA) for alleged overcharging of drug prices by the pharma companies has seen a decline in the year 2023-24, as compared to the previous year. The total amou......
View Details
Source : Pharmabiz
cases
National Pharmaceutical Pricing Authority
NPPA
overcharging
drug prices
interest
suo-moto recovery
Drugs Prices Control Order
DPCO 2013
‘Pharma Jan Samadhan
CPGRAMS
Pharma Sahi Daam App 2.0
iOS platform
Related News
- During FY24, Export and import of bulk drugs was ₹39,632 Crore and ₹37,722 Crore: Economic Survey 2024 (22-07-2024)
- India paves way for a cheaper anti-TB drug for kids (22-07-2024)
- Pharma MNCs seek relief from price control for patented drugs (22-07-2024)
- FPME calls for trial run ahead of February 2025 track and trace implementation (22-07-2024)
- Health facilities employing unqualified staff, verify credentials: Delhi Medical Council (22-07-2024)
- NCB seizes 3,000 Codeine cough syrup bottles, three held (21-07-2024)
- DCA seizes banned 'Ofloxacin and Ornidazole' Suspension (21-07-2024)
- Telangana: Medical Devices Park expansion in limbo (21-07-2024)
- Madras High Court notice to Center on three new criminal laws (21-07-2024)
- Blood cancer medication makes radiation therapy on brain tumours more effective, study reveals (21-07-2024)